Rigontec is the leader in RIG-I targeting therapeutics. Utilizing our proprietary RIG-I agonist platform, we harness one of the most essential pathways in the innate immune system to pioneer a novel immuno-oncology treatment approach.

Corporate Re-Design and relaunch of the new Website

Rebrands can be tough. Between determining strategy, developing a new visual style, redesigning the website, and—perhaps most importantly—aligning all decision makers, it seems as if there are a million things to consider. And of course, the public perception of your company hinges on all of these efforts.

Please visit Rigontec here